TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $239,000 | -98.7% | 16,583 | +1524.2% | 0.04% | +616.7% |
| Q1 2021 | $19,000,000 | -97.6% | 1,021 | -97.6% | 0.01% | -95.0% |
| Q4 2020 | $784,000,000 | +619.3% | 43,088 | +602.6% | 0.12% | +69.0% |
| Q3 2020 | $109,000,000 | -77.9% | 6,133 | -75.4% | 0.07% | +42.0% |
| Q4 2019 | $493,000,000 | – | 24,978 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |